Vitamins - what is the evidence? Rohan Subasinghe.

Slides:



Advertisements
Similar presentations
University of Georgia Cooperative Extension. Why Change Eating Habits? To prevent complications of diabetesTo prevent complications of diabetes –by keeping.
Advertisements

Statins in Renal Failure Andrea Fox Sunnybrook Health Science Center May 2010.
Medical Statistics Joan Morris Professor of Medical Statistics Goldsmiths Lecture 2014.
Cardiovascular outcome in patients with dysglycemia with daily supplementation of n-3 fatty acids 1 ORIGIN trial (Outcome Reduction with an Initial Glargine.
METHODS A systematic review of evidence-based literature was performed using Medline and Cochrane databases. Studies reviewed include randomized controlled.
CAPRIE: Clopidogrel versus Aspirin in Patients at risk of Ischemic Events Purpose To assess the relative efficacy of the antiplatelet drugs clopidogrel.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2009.
Take Your Renal Vitamins!. Why Renal Vitamins? Some vitamins are dialyzed out during treatment You may not be getting enough because you are avoiding.
Enhanced recovery meta-analysis Kirsty Cattle Research Registrar.
Women’s Health Study: Vitamin E in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Julie E. Buring.
Vitamins B, E, and Health Partha Paul Endocrinology Rounds.
Taking Supplements for Nutrition VS. Eating Whole Foods to Obtain Nutrients “Let food be thy medicine and medicine be thy food”-Hippocrates.
 In the U.S.A. over 40 percent of population use dietary supplements. It should be used to correct a deficiency of a specific nutrients.
Women's Health Study: Low-Dose Aspirin in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Dr.
Dietetic Guidelines for Secondary Prevention of Cardiovascular Disease Alison Mead Chief Dietitian On behalf of UK Heart Health and Thoracic Dietitian’s.
1 Therapies Not Indicated Andrew P. DeFilippis, Ty J. Gluckman, James Mudd, Catherine Campbell, Gregg Fonarow & Roger S. Blumenthal.
“Fighting Cancer: It’s All We Do.” ™. Restoring Quality of Life And Managing Side Effects Ulka Vaishampayan M.D. Chair, GU Multidisciplinary team Associate.
Healthy Before Pregnancy March of Dimes NC Preconception Health Campaign.
Multivitamin Misconceptions Gary E. Foresman, M.D. Middle Path Medicine January 2011.
Unit 4 Seminar HW205 Vitamin Classifications and Your Health.
A Randomized Trial of a Multivitamin in the Prevention of Cardiovascular Disease in Men: The Physicians’ Health Study II HD Sesso, WC Christen, V Bubes,
Pravastatin in Elderly Individuals at Risk of Vascular Disease Presented at Late Breaking Clinical Trials AHA 2002 PROSPER.
Folic Acid : A “B” Vitamin for a Healthier YOU ! Alabama Department of Public Health’s Alabama Folic Acid Council and the University of South Alabama's.
Journal Club Hallie Lee PharmD Candidate 2013 Mercer University COPHS PHA 618 Geriatrics-Continuous Care Multivitamins in the Prevention of Cardiovascular.
Mary Hannon-Fletcher Micronutrient supplementation in haemodialysis patient enhances folate levels and reduces homocysteine 4th Annual Translational Medicine.
Taking Vitamins, Is it Necessary? Randa N. Madrigal Kaplan University HW499.
Plasma Homocysteine and Coronary Heart Disease David S. Rosenblatt, MD Department of Human Genetics McGill University.
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
Modules 3-1/4-2/4-3 Promoting Health. Adult Health Immune System  Capacity declines after age 20, partially due to thymus and inability to produce mature.
Placebo-Controls in Short-Term Clinical Trials of Hypertension Sana Al-Khatib, MD, MHS Assistant Professor of Medicine Division of Cardiology Duke University.
UNIT 5 SEMINAR NS 220 Module 5: Vitamins and Health.
Should developing countries continue to use older drugs for essential hypertension? A prescription survey in South Africa suggested that prescribers were.
Copyleft Clinical Trial Results. You Must Redistribute Slides HYVET Trial The Hypertension in the Very Elderly Trial (HYVET)
Spina Bifida Association of America Mission: To promote the prevention of spina bifida and to enhance the lives of all affected Local Group Members 59.
Bioavailibility and Effect on Lipid Metabolism of Crude β- Carotene Extract from Sweet Potato Leaves and Synthetic β- Carotene in Rats Fed Different High.
Preventive Healthcare for Older Adults Framing the Issue.
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
Ref: Craig W; ‘Nutrition and Wellness’ Wahlqvist M; ‘Food and Nutrition’ 2002 Prepared by Sibilla Johnson, B.Sc. Nutrition Unit 14.
VBWG HOPE-TOO: Results of the HOPE Study Extension.
Norwegian Vitamin Trial NORVITNORVIT Presented at The European Society of Cardiology Congress 2005 Presented by Dr. Kaare Harold Bønaa.
N-3fatty acids in cardiovascular disease DR.AMINI.
Sifting through the evidence Sarah Fradsham. Types of Evidence Primary Literature Observational studies Case Report Case Series Case Control Study Cohort.
The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. N Engl J Med 2006; available at: End pointActive therapy PlaceboRelative.
Flow Diagram of Identification of Randomized Trials for Inclusion Goran Bjelakovic, et al. JAMA. 2007;297:
Selenium supplementation for the primary prevention of cardiovascular disease: a Cochrane review Clinical
Can Folic Acid Prevent AMD? Rick Trevino, OD Evansville VA Clinic
Global Evidence for the Use of Calcium for PE/E Prevention Jeffrey Michael Smith, MD, MPH Jhpiego / Johns Hopkins University Maternal Health Team Leader.
The evidence for going to scale with Calcium supplementation Harshad Sanghvi Vice-President & Medical Director, Jhpiego Senior Advisor, Accelovate/USAID,
Unit 4 Seminar HW205 Vitamin Classifications and Your Health Kim Montgomery MS, NBT.
The FAVORIT Study (Folic Acid for Vascular Outcome Reduction in Transplantation) Source Bostom AG, Carpenter MA, Kusek JW, et al. Homocysteine-lowering.
Title slide.
James M. Roberts, M.D., Leslie Myatt, Ph.D.,et al.
HOPE: Heart Outcomes Prevention Evaluation study
Characteristics of the Folic Acid and Placebo Groups at the Start of the Study J. Durga et al. Arch Intern Med. 2005;165:
Pravastatin in Elderly Individuals at Risk of Vascular Disease
The Anglo Scandinavian Cardiac Outcomes Trial
CANTOS: The Canakinumab Anti-Inflammatory Thrombosis Outcomes Study
Insert Objective 1 Insert Objective 2 Insert Objective 3.
Micronutrient supplements in older people- who needs them?
The Hypertension in the Very Elderly Trial (HYVET)
NOACS: Emerging data in ACS/IHD
Dr. PJ Devereaux on behalf of POISE Investigators
Definition of Elderly. Advanced Age and CV Risk: To Start or Not to Start a Statin in Older Patients?
LRC-CPPT and MRFIT Content Points:
HOPE-3 Trial design: Patients without known cardiovascular disease, and with an intermediate risk of cardiovascular events, were randomized in a 2 x 2.
(Micro)nutrient intervention to prevent age-related immune decline
Level of Evidence Lecture 4.
The following slides highlight a report on a presentation at the American College of Cardiology 2004, Scientific Sessions, in New Orleans, Louisiana on.
Research shows that women can reduce their risks of having a baby with a neural tube defect by taking folic acid, or folate, which is a B vitamin. Folic.
Presentation transcript:

Vitamins - what is the evidence? Rohan Subasinghe

What we know already Billion dollar industry One in 3 women and 4 women take vitamins 25% older people take nutritional supplements Folate,Vit B 6 /12 deficiency related to homocysteine levels which is an independent risk factor for CVD/CHD. Higher concentrations have not been shown to reverse the disease process. Folate reduces spina bifida and other neural defects by 80% Vitamins early in life could lead to asthma and food allergies risks Beta carotene has small adverse effect on all cause CV death

Folic acid HOPE2 – 5522 with CV disease randomized to VB6+12+folate pill and placebo – lowered homocysteine by 22% but no effect on end points(MI/CVA) NORVIT – 3749 patient - similar study - trend towards increase inn fatal/non fatal MI and CVA Meta analysis of 12RCTS – folic acid does not reduce events or all cause mortality in patients with vascular disease. Low folate levels may protect against colorectal cancer

Multivitamins MAVIS – double blind RCT – Multivitamins on morbidity from infections in older people – - no effect on self reported infections, prescriptions, QOL, primary care contact Meta analysis of RCTs – litlle evidence to suggest multivitamins and minerals prevent infections in elderly people

Anti-oxidants Meta analysis – (USA) patients in 19 trials - high dosage Vit E may increase all cause mortality. Meta analysis of 14 trials – patients – Vit A,C,E and cancers – none were protective – 1)combination of A and beta carotene = 30 % incr. Risk of death. 2)combination of beta carotene and E=10% increase

Recent evidence – Dr Goran Bjelakovic and colleagues at Copenhagen University Systematic Reviewin examining the literature investigating the effects on mortality of antioxidant supplements. They looked for all primary and secondary preventative randomised controlled trials conducted in adults randomised controlled trials They looked at trials of any antioxidant supplement taken in any dose, form, combination or for any duration of time; including - vitamins A, C and E, beta- carotene and selenium compared with either an inactive placebo or no treatment.

Results and conclusion 13.1% of those taking antioxidants died 10.5% of those taking placebo or no treatment died. C Combining the studies found there was no significant effect of antioxidant supplements on mortality “no evidence to support antioxidant supplements for primary or secondary prevention [of mortality]” Vitamins A, E and beta-carotene may even increase risk of mortality.

Contd.. the researchers also found increased risk of death from any cause from 1)vitamin A (16%), 2)beta-carotene (7%) and 3)vitamin E (4%), There were no significant effects on mortality from either vitamin C or selenium

Criticisms of review Variable quality and inclusion criteria Different doses and combinations Did not examine other specific health benefits, e.g. increased energy, increased resistance to illness etc. most trials used supplement doses that were much higher than those found in a normal diet and sometimes higher than recommended daily intake levels. Trials on specific antioxidants only jsut reached statistical significance

Link to study ane/clsysrev/articles/CD007176/frame.html ane/clsysrev/articles/CD007176/frame.html